Mediwelcome Healthcare Management & Technology Management
Management criteria checks 4/4
We currently do not have sufficient information about the CEO.
Key information
Liang Wang
Chief executive officer
CN¥691.0k
Total compensation
| CEO salary percentage | 86.8% |
| CEO tenure | 5.2yrs |
| CEO ownership | 6.0% |
| Management average tenure | 5.2yrs |
| Board average tenure | 4.5yrs |
Recent management updates
Recent updates
There's No Escaping Mediwelcome Healthcare Management & Technology Inc.'s (HKG:2159) Muted Revenues Despite A 25% Share Price Rise
Oct 03
Mediwelcome Healthcare Management & Technology Inc. (HKG:2159) Surges 28% Yet Its Low P/S Is No Reason For Excitement
Jun 18Improved Revenues Required Before Mediwelcome Healthcare Management & Technology Inc. (HKG:2159) Shares Find Their Feet
Mar 06There's No Escaping Mediwelcome Healthcare Management & Technology Inc.'s (HKG:2159) Muted Revenues
Aug 15Mediwelcome Healthcare Management & Technology (HKG:2159) Might Be Having Difficulty Using Its Capital Effectively
Aug 12Calculating The Intrinsic Value Of Mediwelcome Healthcare Management & Technology Inc. (HKG:2159)
Apr 08Some Investors May Be Worried About Mediwelcome Healthcare Management & Technology's (HKG:2159) Returns On Capital
Jan 24CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -CN¥81m |
| Mar 31 2024 | n/a | n/a | -CN¥87m |
| Dec 31 2023 | CN¥691k | CN¥600k | -CN¥94m |
| Sep 30 2023 | n/a | n/a | -CN¥86m |
| Jun 30 2023 | n/a | n/a | -CN¥79m |
| Mar 31 2023 | n/a | n/a | -CN¥84m |
| Dec 31 2022 | CN¥2m | CN¥570k | -CN¥89m |
| Sep 30 2022 | n/a | n/a | -CN¥57m |
| Jun 30 2022 | n/a | n/a | -CN¥26m |
| Mar 31 2022 | n/a | n/a | -CN¥11m |
| Dec 31 2021 | CN¥3m | CN¥650k | CN¥5m |
| Sep 30 2021 | n/a | n/a | CN¥6m |
| Jun 30 2021 | n/a | n/a | CN¥8m |
| Mar 31 2021 | n/a | n/a | CN¥14m |
| Dec 31 2020 | CN¥662k | CN¥600k | CN¥21m |
| Sep 30 2020 | n/a | n/a | CN¥19m |
| Jun 30 2020 | n/a | n/a | CN¥16m |
| Mar 31 2020 | n/a | n/a | CN¥18m |
| Dec 31 2019 | CN¥665k | CN¥573k | CN¥21m |
Compensation vs Market: Liang's total compensation ($USD95.43K) is below average for companies of similar size in the Hong Kong market ($USD233.55K).
Compensation vs Earnings: Liang's compensation has been consistent with company performance over the past year.
CEO
Liang Wang (48 yo)
5.2yrs
Tenure
CN¥691,000
Compensation
Mr. Liang Wang serves as the Chief Executive Officer at Mediwelcome Healthcare Management & Technology Inc. and has been its Executive Director since September 18, 2019. Mr. Wang co-founded Mediwelcome Gro...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman of the Board | 5.8yrs | CN¥691.00k | 20.33% HK$ 15.0m | |
| CEO & Executive Director | no data | CN¥691.00k | 6.02% HK$ 4.5m | |
| Executive Vice Chairman of the Board | 5.2yrs | CN¥691.00k | 12.71% HK$ 9.4m | |
| CFO & Executive Director | no data | no data | no data | |
| Chief Technology Officer | no data | no data | no data | |
| VP of Human Resources & Joint Company Secretary | 5.2yrs | no data | no data | |
| Joint Company Secretary | 3.1yrs | no data | no data |
5.2yrs
Average Tenure
48yo
Average Age
Experienced Management: 2159's management team is seasoned and experienced (5.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman of the Board | 5.8yrs | CN¥691.00k | 20.33% HK$ 15.0m | |
| CEO & Executive Director | 5.2yrs | CN¥691.00k | 6.02% HK$ 4.5m | |
| Executive Vice Chairman of the Board | 5.2yrs | CN¥691.00k | 12.71% HK$ 9.4m | |
| CFO & Executive Director | less than a year | no data | no data | |
| Independent Non-Executive Director | 3.9yrs | CN¥321.00k | no data | |
| Independent Non-Executive Director | 3.9yrs | CN¥229.00k | no data | |
| Independent Non-Executive Director | 3.9yrs | CN¥227.00k | no data | |
| Non-Executive Director | 5.2yrs | no data | no data |
4.5yrs
Average Tenure
48yo
Average Age
Experienced Board: 2159's board of directors are considered experienced (4.5 years average tenure).